Concepedia

J. L. Gilfillan

JL

Statistics

Publications

11

Citations

500

H-Index

11

Active since

1955

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

J. L. Gilfillan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, life sciences, and enzyme inhibition.

Publications per year

1955–1991

11

Publications

11

Effect of Cholestyramine, A Bile Acid Binding Polymer on Plasma Cholesterol and Fecal Bile Acid Excretion in the Rat

Jesse W. Huff, J. L. Gilfillan, V. M. Hunt · Experimental Biology and Medicine · 1963 · 124 citations

, , +17

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. I. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives

G. E. STOKKER, William F. Hoffman, Alfred W. Alberts et al. · Journal of Medicinal Chemistry · 1985 · 109 citations · Full text

, , +8

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted-[1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives

G. E. STOKKER, Alfred W. Alberts, Paul Anderson et al. · Journal of Medicinal Chemistry · 1986 · 68 citations · Full text

, , +16

The Absorption and Excretion of Orally Administered Nicarbazin by Chickens

Curt C. Porter, J. L. Gilfillan · Poultry Science · 1955 · 43 citations · Full text

, , +15

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives

William F. Hoffman, Alfred W. Alberts, Edward J. Cragoe et al. · Journal of Medicinal Chemistry · 1986 · 34 citations

, , +8

1–5 of 11